Emerald Mutual Fund Advisers Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-230
Closed -$175K – 209
2025
Q3
$175K Sell
230
-108
-32% -$80.4K 0.01% 196
2025
Q2
$263K Sell
338
-86
-20% -$66.8K 0.02% 176
2025
Q1
$350K Sell
424
-48
-10% -$39.9K 0.02% 165
2024
Q4
$364K Sell
472
-90
-16% -$74.5K 0.02% 166
2024
Q3
$498K Buy
562
+244
+77% +$219K 0.03% 161
2024
Q2
$288K Buy
318
+106
+50% +$84.8K 0.02% 175
2024
Q1
$165K Sell
212
-7
-3% -$4.98K 0.01% 197
2023
Q4
$128K Buy
+219
New +$128K 0.01% 230
2023
Q1
– Sell
-258
Closed -$94.4K – 245
2022
Q4
$94.4K Sell
258
-23
-8% -$8.15K 0.01% 204
2022
Q3
$91K Sell
281
-17
-6% -$5.39K 0.01% 208
2022
Q2
$97K Buy
+298
New +$89.5K 0.01% 201

Other funds holding LLY

Emerald Mutual Fund Advisers Trust's LLY Position: Q4 2025 in Review

Emerald Mutual Fund Advisers Trust sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 230 shares — an estimated $175K sold.

Emerald Mutual Fund Advisers Trust first reported a position in LLY in Q2 2022 and held it in 11 quarters. The position peaked at $498K in Q3 2024. 4,449 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Emerald Mutual Fund Advisers Trust reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 230 Eli Lilly shares in Q4 2025, an estimated $175K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Eli Lilly in Q2 2022 and held it in 11 quarters.
  • Emerald Mutual Fund Advisers Trust's Eli Lilly position peaked at $498K in Q3 2024.
  • 4,449 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2025, filed 9 Feb 2026.